Line 7: |
Line 7: |
| To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. |
| | | |
− | ==WHO Classification of Tumours of the Breast (5th Edition) Content== | + | <br /> |
− | {| class="wikitable"
| + | {| class="wikitable" style="margin:auto" |
| + | |+<big>WHO Classification of Tumours of the Breast (5th Edition) Content</big> |
| |- | | |- |
| !'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' | | !'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author''' |
Line 17: |
Line 18: |
| !'''Date of Last Editor Review''' | | !'''Date of Last Editor Review''' |
| !'''Notes''' | | !'''Notes''' |
− | |- |Usual ductal hyperplasia||Disease|| | + | |- |
| + | |CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | |- |
| |Usual Ductal Hyperplasia | | |Usual Ductal Hyperplasia |
| |Disease | | |Disease |
| + | | |
| + | | |
| + | | |
| | | | | |
| | | | | |
Line 296: |
Line 320: |
| | | | | |
| |- | | |- |
− | |Acinic Cell Carcinoma||Disease|| | + | |[[BRST5:Acinic Cell Carcinoma|Acinic Cell Carcinoma]]||Disease||Patricija Zot |
− | | | + | |2/28/2024 |
− | |
| |
− | |
| |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Katherine Geiersbach |
| | | | | |
| | | | | |
| |- | | |- |
− | |Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao | + | |[[BRST5:Adenoid Cystic Carcinoma|Adenoid Cystic Carcinoma]]||Disease||Katherine Geiersbach / Jun Liao |
| |10/12/02022 | | |10/12/02022 |
| |11/11/2023 | | |11/11/2023 |
Line 314: |
Line 338: |
| |2021 template added | | |2021 template added |
| |- | | |- |
− | |Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi | + | |[[BRST5:Secretory Carcinoma|Secretory Carcinoma]]||Disease||Hui Chen / Morteza Seifi |
| |10/12/2022 | | |10/12/2022 |
| |11/11/2023 | | |11/11/2023 |
− | |PENDING | + | |COMPLETE |
| | | | | |
| |Katherine Geiersbach | | |Katherine Geiersbach |
Line 341: |
Line 365: |
| | | | | |
| |- | | |- |
− | |Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce | + | |[[BRST5:Tall Cell Carcinoma with Reversed Polarity|Tall Cell Carcinoma with Reversed Polarity]]||Disease||H. Evin Gulbahce |
| |8/11/2023 | | |8/11/2023 |
| |10/11/2023 | | |10/11/2023 |
Line 367: |
Line 391: |
| | | | | |
| | | | | |
| + | |- |
| + | |CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
| |Hamartoma||Disease|| | | |Hamartoma||Disease|| |
Line 377: |
Line 421: |
| | | | | |
| |- | | |- |
− | |Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot | + | |[[BRST5:Fibroadenoma|Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot |
| |8/11/2023 | | |8/11/2023 |
| |11/11/2023 | | |11/11/2023 |
Line 386: |
Line 430: |
| |2021 template added | | |2021 template added |
| |- | | |- |
− | |Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach | + | |[[BRST5:Phyllodes Tumour|Phyllodes Tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach |
| |8/11/2023 | | |8/11/2023 |
| |11/11/2023 | | |11/11/2023 |
− | |PENDING | + | |COMPLETE |
| | | | | |
| | | | | |
| | | | | |
| |2021 template added | | |2021 template added |
| + | |- |
| + | |CHAPTER 4 (TUMOURS OF THE NIPPLE) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
| |Syringomatous Tumour||Disease|| | | |Syringomatous Tumour||Disease|| |
Line 421: |
Line 485: |
| | | | | |
| | | | | |
| + | |- |
| + | |CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
| |Haemangioma||Disease|| | | |Haemangioma||Disease|| |
Line 494: |
Line 578: |
| | | | | |
| |- | | |- |
− | |Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu | + | |[[BRST5:Inflammatory Myofibroblastic Tumour|Inflammatory Myofibroblastic Tumour]]||Disease||Yajuan Liu |
| |8/11/2023 | | |8/11/2023 |
| |11/11/2023 | | |11/11/2023 |
Line 583: |
Line 667: |
| | | | | |
| | | | | |
| + | |- |
| + | |CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
| |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| | | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease|| |
Line 628: |
Line 732: |
| | | | | |
| | | | | |
| + | |- |
| + | |CHAPTER 7 (TUMOURS OF THE MALE BREAST) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
| |Gynaecomastia||Disease|| | | |Gynaecomastia||Disease|| |
Line 664: |
Line 788: |
| | | | | |
| | | | | |
| + | |- |
| + | |CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST) |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| + | | |
| + | ---- |
| |- | | |- |
| |BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach | | |BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach |
Line 670: |
Line 814: |
| | | | | |
| | | | | |
| + | |Katherine Geiersbach |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
− | |
| |
| |- | | |- |
| |Cowden Syndrome||Disease|| | | |Cowden Syndrome||Disease|| |
Line 681: |
Line 825: |
| | | | | |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[Cowden Syndrome]]" in GTS5 book. Will later add breast book link redirecting to this DIG5 book page (need to correlate with related volunteer page - [[DIG5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
| |Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach | | |Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach |
Line 690: |
Line 834: |
| |Katherine Geiersbach | | |Katherine Geiersbach |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[Ataxia-Telangiectasia Syndrome (ATM)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
| |Li-Fraumeni Syndrome, TP53-Associated||Disease|| | | |Li-Fraumeni Syndrome, TP53-Associated||Disease|| |
Line 699: |
Line 843: |
| | | | | |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[Li-Fraumeni Syndrome (TP53)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
| |Li-Fraumeni Syndrome, CHEK2-Associated||Disease|| | | |Li-Fraumeni Syndrome, CHEK2-Associated||Disease|| |
Line 708: |
Line 852: |
| | | | | |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
| |CDH1-Associated Breast Cancer||Disease|| | | |CDH1-Associated Breast Cancer||Disease|| |
Line 717: |
Line 861: |
| | | | | |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
− | |PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach | + | |PALB2-Associated Cancers||Disease||Jun Liao / Constance Albarracin / Katherine Geiersbach |
| |12/8/2023 | | |12/8/2023 |
| |3/8/2024 | | |3/8/2024 |
| | | | | |
| | | | | |
| + | |Katherine Geiersbach |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[PALB2-Related Cancer Predisposition Syndrome (PALB2)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
− | |
| |
| |- | | |- |
| |Peutz-Jeghers Syndrome||Disease|| | | |Peutz-Jeghers Syndrome||Disease|| |
Line 735: |
Line 879: |
| | | | | |
| | | | | |
− | | | + | |NOT YET CREATED - See page "[[Peutz-Jeghers Syndrome (STK11)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
| |Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova | | |Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova |
Line 744: |
Line 888: |
| | | | | |
| | | | | |
− | |NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content. | + | |NOT YET CREATED - See page "[[Neurofibromatosis Type 1 (NF1)]]" in GTS5 book. Will later add breast book link redirecting to this GTS5 book page (need to correlate with related volunteer page - [[GTS5:Volunteer Assignments and Opportunities]]). |
| |- | | |- |
− | |Polygenic Component of Breast Cancer Susceptibility | + | |[[BRST5:Polygenic Component of Breast Cancer Susceptibility|Polygenic Component of Breast Cancer Susceptibility]] |
| |Disease | | |Disease |
| | | | | |
Line 755: |
Line 899: |
| | | | | |
| | | | | |
− | | | + | |Template added (12/30/23) |
| |- | | |- |
| |}<br /> | | |}<br /> |